George D. Yancopoulos
2006
In 2006, George D. Yancopoulos earned a total compensation of $2.5M as Executive Vice President, Chief Scientific Officer and President Regeneron Research Laboratories at Regeneron Pharmaceuticals.
Compensation breakdown
| Bonus | $335,000 |
|---|---|
| Option Awards | $1,593,780 |
| Salary | $544,300 |
| Other | $22,155 |
| Total | $2,495,235 |
Yancopoulos received $1.6M in option awards, accounting for 64% of the total pay in 2006.
Yancopoulos also received $335K in bonus, $544.3K in salary and $22.2K in other compensation.
Rankings
In 2006, George D. Yancopoulos' compensation ranked 1,375th out of 7,022 executives tracked by ExecPay. In other words, Yancopoulos earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,375 out of 7,022 | 80th |
Division Manufacturing | 428 out of 2,413 | 82nd |
Major group Chemicals And Allied Products | 73 out of 673 | 89th |
Industry group Drugs | 39 out of 518 | 93rd |
Industry Pharmaceutical Preparations | 33 out of 355 | 91st |
Source: SEC filing on April 24, 2009.
Yancopoulos' colleagues
We found four more compensation records of executives who worked with George D. Yancopoulos at Regeneron Pharmaceuticals in 2006.
2006
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2006
Neil Stahl
Regeneron Pharmaceuticals
Senior Vice President, Research Development Sciences
2006
Murray Goldberg
Regeneron Pharmaceuticals
Chief Financial Officer
2006
Randall Rupp
Regeneron Pharmaceuticals
Senior Vice President, Manufacturing Operations
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019